This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Treatment Patterns in Castrate Resistant Prostate ...
Clinical trial

Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population

Read time: 1 mins
Last updated:1st Aug 2015

The goal of the study is to provide a detailed description of treatments for CRPC (Castrate Resistant Prostate Cancer) patients with bone metastases and the resource utilization and costs associated with that diagnosis and subsequent treatments.

Study Type: Observational

Observational Model: Cohort

Time Perspective: Retrospective

Official Title: Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases

Estimated Enrollment: 1100

Study Start Date: August 2015

Estimated Study Completion Date: December 2016

Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)


Patients with castrated resistant prostate cancer and bone metastases

Category Value
Study start date 2015-08-01

View full details